233 related articles for article (PubMed ID: 28006083)
1. Definitive carbon-ion radiotherapy for locally advanced parotid gland carcinomas.
Koto M; Hasegawa A; Takagi R; Ikawa H; Naganawa K; Mizoe JE; Jingu K; Tsujii H; Tsuji H; Kamada T; Okamoto Y;
Head Neck; 2017 Apr; 39(4):724-729. PubMed ID: 28006083
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.
Al-Mamgani A; van Rooij P; Verduijn GM; Meeuwis CA; Levendag PC
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):189-95. PubMed ID: 22330990
[TBL] [Abstract][Full Text] [Related]
3. Mucoepidermoid carcinoma of the parotid gland: A National Cancer Database study.
Rajasekaran K; Stubbs V; Chen J; Yalamanchi P; Cannady S; Brant J; Newman J
Am J Otolaryngol; 2018; 39(3):321-326. PubMed ID: 29559174
[TBL] [Abstract][Full Text] [Related]
4. Definitive Carbon-Ion Radiation Therapy for Locally Advanced Sinonasal Malignant Tumors: Subgroup Analysis of a Multicenter Study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
Koto M; Demizu Y; Saitoh JI; Suefuji H; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Ikawa H; Nemoto K; Nakano T; Kamada T;
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):353-361. PubMed ID: 30191869
[TBL] [Abstract][Full Text] [Related]
5. Clinical prognostic factors in malignant parotid gland tumors.
Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors and Clinical Outcome in Parotid Gland Tumors: a Single Institution Experience from the Eastern Black Sea Region of Turkey.
Kandaz M; Soydemir G; Bahat Z; Canyilmaz E; Yoney A
Asian Pac J Cancer Prev; 2016; 17(3):1169-74. PubMed ID: 27039743
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the safety and efficacy of carbon ion radiotherapy for locally advanced adenoid cystic carcinoma of the tongue base.
Koto M; Hasegawa A; Takagi R; Ikawa H; Naganawa K; Mizoe JE; Jingu K; Tsujii H; Tsuji H; Kamada T; Okamoto Y;
Head Neck; 2016 Apr; 38 Suppl 1():E2122-6. PubMed ID: 26854882
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
Choi SY; Lee E; Kim E; Chung MK; Son YI; Baek CH; Jeong HS
BMC Cancer; 2021 Feb; 21(1):178. PubMed ID: 33602169
[TBL] [Abstract][Full Text] [Related]
9. Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients.
Zhan KY; Huang AT; Khaja SF; Bell D; Day TA
Head Neck; 2016 Aug; 38(8):1208-12. PubMed ID: 27166875
[TBL] [Abstract][Full Text] [Related]
10. Management of minor salivary gland carcinomas.
Parsons JT; Mendenhall WM; Stringer SP; Cassisi NJ; Million RR
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):443-54. PubMed ID: 8655366
[TBL] [Abstract][Full Text] [Related]
11. Survival in patients with parotid gland carcinoma - Results of a multi-center study.
Honda K; Tanaka S; Shinohara S; Asato R; Tamaki H; Maetani T; Tateya I; Kitamura M; Takebayashi S; Ichimaru K; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Mizuta M; Yamada K; Omori K
Am J Otolaryngol; 2018; 39(1):65-70. PubMed ID: 29089142
[TBL] [Abstract][Full Text] [Related]
12. Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?
Jensen AD; Poulakis M; Vanoni V; Uhl M; Chaudhri N; Federspil PA; Freier K; Krauss J; Debus J
Radiat Oncol; 2016 Jul; 11(1):90. PubMed ID: 27386864
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiotherapy for malignant tumors of the parotid gland.
Garden AS; el-Naggar AK; Morrison WH; Callender DL; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):79-85. PubMed ID: 9054880
[TBL] [Abstract][Full Text] [Related]
14. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.
Huang BS; Chen WY; Hsieh CE; Lin CY; Lee LY; Fang KH; Tsang NM; Kang CJ; Wang HM; Chang JT
Jpn J Clin Oncol; 2016 Sep; 46(9):832-8. PubMed ID: 27317738
[TBL] [Abstract][Full Text] [Related]
16. Carcinomas arising in the submandibular gland: high propensity for systemic failure.
Roh JL; Choi SH; Lee SW; Cho KJ; Nam SY; Kim SY
J Surg Oncol; 2008 May; 97(6):533-7. PubMed ID: 18286522
[TBL] [Abstract][Full Text] [Related]
17. The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid gland.
Chen AM; Garcia J; Bucci MK; Quivey JM; Eisele DW
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):138-43. PubMed ID: 17049183
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and outcome analysis of submandibular gland cancer: a clinical audit.
Mallik S; Agarwal J; Gupta T; Kane S; Laskar SG; Budrukkar A; Murthy V; Goel V; Jain S
J Oral Maxillofac Surg; 2010 Sep; 68(9):2104-10. PubMed ID: 20538399
[TBL] [Abstract][Full Text] [Related]
19. High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy.
Jensen AD; Poulakis M; Nikoghosyan AV; Welzel T; Uhl M; Federspil PA; Freier K; Krauss J; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Radiother Oncol; 2016 Feb; 118(2):272-80. PubMed ID: 26164774
[TBL] [Abstract][Full Text] [Related]
20. Recurrent cancer of the parotid gland: how well does salvage surgery work for locoregional failure?
Kobayashi K; Nakao K; Yoshida M; Ando M; Ebihara Y; Asakage T; Yamasoba T
ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):239-43. PubMed ID: 19738397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
